Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ipratropium/Salbutamol Respimat vs Combivent MDI in COPD
NCT02177253Phase 3Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Oct 2002
- Primary completion
- Mar 2004
- Modality
- Implantable Devices, Transdermal Patches, Inhalation Devices
01
Overview
A Phase 3 trial of Combivent in chronic obstructive pulmonary disease (COPD), sponsored by Boehringer Ingelheim. Started Oct 2002; status: completed.
02
Drugs
Combivent
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT02177253.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02177253.